Mineralocorticoid receptor modulators

Details for Australian Patent Application No. 2008339007 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Steen, Justin T.; Brandish, Philip E.; Hershey, James C.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-A-2008339007

PCT Pub. Number WO2009/078934

Priority 61/007,640 14.12.07 US

Filing date 10 December 2008

Wipo publication date 25 June 2009

International Classifications

C07D 213/00 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/33 (2006.01) - Heterocyclic compounds

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/078934 Priority application(s): WO2009/078934

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339013-Modular mobile robot

2008339005-3,4-substituted pyrrolidine betasecretase inhibitors for the treatment of alzheimer's disease